Venous Thromboembolism (VTE) Recent Advances in Reducing the Disease Burden Gary E. Raskob, Ph. D. Dean, College of Public Health Regents Professor, Epidemiology and Medicine…
Slide 1 Neue Antikoagulantien bei spontaner und Tumor-assoziierter VTE Paul Kyrle Univ. Klinik f. Innere Medizin I AKH/Medizinische Universität Wien Slide 2 Treatment of…
Slide 1 Excellence Begins Here Slide 2 Board of Directors Jack Ansell, MD Allison Burnett, PharmD David Garcia, MD Scott Kaatz, DO Renato Lopes, MD Edith Nutescu, PharmD…
FDA Review of Clinical Data Fragmin® (Dalteparin sodium injection) for treatment of VTE in cancer patients Medical Officer: Andrew Dmytrijuk, MD FDA/Center for Drug Evaluation…
Overview of Target-Specific Oral Anticoagulants (TSOACs) Overview of Target-Specific Oral Anticoagulants (TSOACs) The Blood Thins and the Plot Thickens American College of…
September 2010 PenCLAHRC: Peninsula Collaboration for Leadership in Applied Health Research and Care. Research Findings in Risk Assessment for VTE in the South West The Researchers…
Levine in Dr. Ssa Marina Minozzi Oncologia âLa Sapienzaâ Polo Pontino 1 The VTE clinical practice recommendations were developed to guide practicing clinicians on the best…
Official Topic from UpToDate®, the clinical decision support resource accessed by 700,000+ clinicians worldwide. Available via the web and mobile devices, subscribe to…